Chong Kun Dang enters 'fifth' P1 study of diabetes combo drug < Pharma < 기사본문 - KBR

Diabetes Tips, News & Articles

Chong Kun Dang recently received regulatory approval to conduct its fifth phase 1 clinical trial of CKD-393, a new drug candidate for diabetes, ...
Chong Kun Dang recently received regulatory approval to conduct its fifth phase 1 clinical trial of CKD-393, a new drug candidate for diabetes, ...
Read more
Note: This news content is auto-generated from a syndicated feed.

If you have a family history of diabetes you could be at risk, get tested now! Book Diabetes test online

Popular posts from this blog

How the timing of dinner and genetics affect individuals' blood sugar control - ScienceDaily

Coronapod: COVID and diabetes, what the science says - Nature

Sciwind Biosciences Announces Initiation of Dosing in Phase 1 Clinical Trial Evaluating ...